foxo4-dri peptide senolytic 2023 2024 study FOX04-DRI The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research FOXO4 D Retro Inverso(DRI) peptide
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



